PACS Group, Inc. (NYSE:PACS – Get Free Report) CAO Michelle Renee Lewis sold 4,200 shares of PACS Group stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $45.01, for a total transaction of $189,042.00. Following the transaction, the chief accounting officer directly owned 366,138 shares in the company, valued at $16,479,871.38. This trade represents a 1.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Michelle Renee Lewis also recently made the following trade(s):
- On Monday, July 6th, Michelle Renee Lewis sold 4,137 shares of PACS Group stock. The shares were sold at an average price of $45.04, for a total transaction of $186,330.48.
- On Thursday, July 2nd, Michelle Renee Lewis sold 6,663 shares of PACS Group stock. The stock was sold at an average price of $45.03, for a total transaction of $300,034.89.
- On Thursday, June 25th, Michelle Renee Lewis sold 15,000 shares of PACS Group stock. The shares were sold at an average price of $40.01, for a total transaction of $600,150.00.
PACS Group Trading Up 0.7%
PACS opened at $43.93 on Thursday. The stock has a market capitalization of $6.95 billion, a PE ratio of 28.16, a P/E/G ratio of 1.30 and a beta of -0.08. PACS Group, Inc. has a one year low of $7.50 and a one year high of $45.89. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.99 and a current ratio of 0.99. The business’s 50 day moving average price is $37.72 and its 200 day moving average price is $36.84.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Weiss Ratings restated a “hold (c)” rating on shares of PACS Group in a report on Wednesday, June 24th. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. Oppenheimer raised their price objective on shares of PACS Group from $42.00 to $48.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Wall Street Zen raised shares of PACS Group from a “buy” rating to a “strong-buy” rating in a research note on Monday, June 15th. Finally, Truist Financial increased their target price on shares of PACS Group from $50.00 to $52.00 and gave the stock a “buy” rating in a report on Monday, May 18th. Five research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, PACS Group has an average rating of “Moderate Buy” and a consensus price target of $50.60.
Read Our Latest Analysis on PACS
Institutional Trading of PACS Group
Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in PACS Group by 14.4% during the 4th quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock worth $172,994,000 after acquiring an additional 566,502 shares in the last quarter. Crewe Advisors LLC raised its holdings in shares of PACS Group by 93.1% in the 4th quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock valued at $82,455,000 after purchasing an additional 1,035,747 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of PACS Group in the 1st quarter valued at $6,762,000. Corient Private Wealth LLC lifted its position in shares of PACS Group by 29.7% during the 4th quarter. Corient Private Wealth LLC now owns 170,052 shares of the company’s stock worth $6,528,000 after purchasing an additional 38,956 shares during the last quarter. Finally, Maven Securities LTD purchased a new stake in shares of PACS Group during the 4th quarter worth $960,000.
PACS Group Company Profile
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Featured Articles
- Five stocks we like better than PACS Group
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
